
Yannick Jadot Mentions Cherry Biotech’s Organ-on-Chip Technologies
Cherry Biotech Organ-on-a-Chip technologies mentioned as an alternative to animal drug testing by Yannick Jadot during
Cherry Biotech Organ-on-a-Chip technologies mentioned as an alternative to animal drug testing by Yannick Jadot during
Context Solid tumors are characterized by areas of hypoxic tissue heterogeneously distributed inside the tumor mass.
The tumor microenvironment (TME) is a complex biochemical network that includes multiple factors surrounding tumor cells,
Efficacity and toxicity of candidate anticancer drugs on 3D cell culture model has been much lower
Organs-on-Chip for Drug Development A drug should pass the preclinical evaluation phase to be FDA-approved. This
Introduction Drug induced liver injury (DILI)is one of the major reasons of drug attrition and it
Introduction The liver is a fundamental organ for human life. It is responsible for macromolecules (carbohydrates,
Immune Checkpoint Modulators as an emerging therapy Through this paper, Kim and colleagues highlight the way
Immune checkpoint modulation in renal cell carcinoma In this paper, Bedke and colleague highlight the way that patients treated for
Immune Checkpoint Modulators Summary Immune Checkpoint modulators are new promising therapies that specifically target the ability
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com
All right reserved to © Cherry Biotech 2023